Tag: genomics
-
Biotech, Microsoft Partner on Immune System Diagnostics
A company that analyzes immune system genomics is collaborating with Microsoft Corporation to develop early-stage disease diagnostics.
-
Sangamo, Pfizer Partner on ALS Gene Therapy
Drug maker Pfizer Inc. is licensing and collaborating on a gene therapy technology from Sangamo Therapeutics Inc. to treat amyotrophic lateral sclerosis, or ALS, and a related neurodegenerative disease.
-
RNA Therapies Start-Up Raises $55.3M in Early Funds
A start-up company creating treatments for inherited diseases that target faulty RNA transcribed from genetic codes is raising $55.3 million in its first venture funding round.
-
Techniques Devised to Speed-Up Plant Breeding
Plant scientists in Australia and the U.K. developed a process that sharply cuts the amount of time needed to produce new breeds of plant crops including commercial varieties of wheat.
-
Cell Engineering Company Launches, Raises $4.7 Million
A company designing biological circuits with techniques derived from computer-assisted design like those used in semiconductors is starting up in Cambridge, Massachusetts.
-
Finland Begins Large-Scale National Genomic Study
The country of Finland is conducting a nationwide genomic analysis of its population, collecting 500,000 blood samples from its 5.5 million citizens.
-
FDA Approves Gene Therapy for Inherited Vision Loss
A therapy using transfers of healthy genes to treat a rare form of inherited vision loss was approved today by the U.S. Food and Drug Administration.
-
FDA Issues Draft Precision Medicine Trial Guidance
The U.S. Food and Drug Administration issued draft regulatory guidance on clinical trials for new treatments that target genetic mutations rather than disease states.
-
Tobacco Plants Studied as Drug Bio-Factories
A university in Australia is joining a European research project to create new types of tobacco plants for producing pharmaceuticals.
-
Engineered Cells Identify Rare Epilepsy Drug Candidates
A process using high-speed screening of drug candidates with genetically engineered cells identified potential drugs to treat a rare form of childhood epilepsy.